Barbara Waszczak Professor of Pharmaceutical Sciences b.waszczak@neu.edu 617.373.3312 Expertise Neuropharmacology, neuroscience Barbara Waszczak in the Press What We Learned About Hybrid Work in 2022 “It’s more difficult to make blanket statements now than it was even a year ago,” says Barbara Larson, a professor of management at the D’Amore-McKim School of Business at Northeastern University. FierceDrugDelivery Researchers reverse Parkinson’s damage with nasal gene delivery Researchers at Northeastern University have developed a treatment for Parkinson’s disease meant to revive dying neurons in the brain via delivery through the nose. The Boston researchers were able to treat the symptoms of Parkinson’s–a decrease of motor function that results in tremors and slowed movements–with a protein called glial cell line-derived neurotrophic factor, or GDNF. The […] Daily Mirror Parkinson’s disease ‘cure’ is shot up the nose A possible cure to Parkinson’s disease has been developed to be taken through sufferers’ noses. The devastating disorder is caused by the death of dopamine neurons in a key area of the brain. But a gene that restores and protects dopamine can halt Parkinson’s if administered direct to the brain. It was thought this was […] Barbara Waszczak for Northeastern Global News Nasal treatment targets Parkinson’s disease at its roots Nasal treatment targets Parkinson’s disease at its roots Pharmaceutical sciences professor Barbara Waszczak and graduate student Brendan Harmon devised an intranasal gene therapy that targets the underlying cause of Parkinson’s disease, not just its symptoms.
What We Learned About Hybrid Work in 2022 “It’s more difficult to make blanket statements now than it was even a year ago,” says Barbara Larson, a professor of management at the D’Amore-McKim School of Business at Northeastern University.
FierceDrugDelivery Researchers reverse Parkinson’s damage with nasal gene delivery Researchers at Northeastern University have developed a treatment for Parkinson’s disease meant to revive dying neurons in the brain via delivery through the nose. The Boston researchers were able to treat the symptoms of Parkinson’s–a decrease of motor function that results in tremors and slowed movements–with a protein called glial cell line-derived neurotrophic factor, or GDNF. The […]
Daily Mirror Parkinson’s disease ‘cure’ is shot up the nose A possible cure to Parkinson’s disease has been developed to be taken through sufferers’ noses. The devastating disorder is caused by the death of dopamine neurons in a key area of the brain. But a gene that restores and protects dopamine can halt Parkinson’s if administered direct to the brain. It was thought this was […]